Bowenoid Actinic Keratosis and Bowen's Disease Treated Successfully with Ingenol Mebutate.

Ingenol mebutate (IM) is a topical pharmacotherapy approved in Switzerland since 2012 for treating non-hypertrophic, non-hyperkeratotic actinic keratosis (AK). We report 2 cases with off-label use of IM. The first case of bowenoid AK was treated with 150 µg IM for 3 consecutive days with an almost complete clinical remission of the lesion. The second case of Bowen's disease was treated with 500 µg IM for 2 consecutive days leading to complete clinical remission.